Trial to assess dual CAR T-cell therapy for children, young adults with leukemia – Healio
|
Trial to assess dual CAR T-cell therapy for children, young adults with leukemia
Healio A trial is underway to evaluate the use of dual chimeric antigen receptor T-cell immunotherapy for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia. “This is an exciting time where we are at the … |
